Evidence map›Paper›PMID 29563134›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.

Nada Assi, Duncan C Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M Sandanger and 12 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Associations between Metabolomic Signatures of Persistent Smoking Effects and Lung Cancer Risk among Former Smokers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. NMR metabolomic profiles associated with long-term risk of prostate cancer.Metabolomics : Official journal of the Metabolomic Society · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 2 countries.

Nada AssiSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Duncan C ThomasUniversity of Southern California, Los Angeles, California.
Michael LeitzmannDepartment of Epidemiology and Preventive Medicine, Regensburg University, Regensburg, Germany.
Magdalena StepienSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Véronique ChajèsSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Thierry PhilipUnité Cancer et Environnement, Centre Léon Bérard, Lyon, France.
Paolo VineisDepartment of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Christina BamiaHellenic Health Foundation, Athens, Greece.
Marie-Christine Boutron-RuaultUniversité Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.
Torkjel M SandangerDepartment of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.
Amaia MolinuevoPublic Health Division of Gipuzkoa, Regional Government of the Basque Country, Donostia-San Sebastián, Spain.
Hendriek C BoshuizenNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Anneli SundkvistDepartment of Radiation Sciences Oncology, Umeå University, Umeå, Sweden.
Tilman KühnDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ruth C TravisCancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
Kim OvervadThe Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark.
Elio RiboliDepartment of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Marc J GunterSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Augustin ScalbertSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Mazda JenabSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Pietro FerrariSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France. ferrarip@iarc.fr.
Vivian ViallonSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
Institut Gustave Roussy · FRUniversity of Southern California · US

Funding

Statistical Methods for Integrative Genomics in CancerP01CA196569 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul Marjoram · 2016 to 2026
$25.5M
Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI MUIR, TOM · 2015 to 2024
$17.6M
Cancer Research UK 14136Cancer Research UK 16491Cancer Research UK C570/A16491Cancer Research UK C8221/A19170Medical Research Council 1000143Medical Research Council MR/M012190/1NCI NIH HHS P01 CA196539NCI NIH HHS P01 CA196569World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Life StyleMetabolomeAgedBiomarkers, TumorBody Mass IndexCarcinoma, HepatocellularCase-Control StudiesEuropeFemaleHumansLiver Function TestsLiver NeoplasmsMaleMetabolomicsMiddle AgedProspective StudiesBiomarkers, Tumor

Identifiers

PMID29563134
PMCPMC7444360
OpenAlexW2789860708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.